- Home
- GCTS vs COYA Comparison
GCTS vs COYA Comparison
Compare GCTS & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- COYA
- Stock Information
- Founded
- GCTS 1998
- COYA 2020
- Country
- GCTS United States
- COYA United States
- Employees
- GCTS N/A
- COYA N/A
- Industry
- GCTS Blank Checks
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- GCTS Finance
- COYA Health Care
- Exchange
- GCTS Nasdaq
- COYA Nasdaq
- Market Cap
- GCTS 113.6M
- COYA 104.3M
- IPO Year
- GCTS N/A
- COYA 2022
- Fundamental
- Price
- GCTS $2.28
- COYA $5.24
- Analyst Decision
- GCTS Strong Buy
- COYA Strong Buy
- Analyst Count
- GCTS 1
- COYA 4
- Target Price
- GCTS $8.00
- COYA $16.25
- AVG Volume (30 Days)
- GCTS 178.2K
- COYA 78.0K
- Earning Date
- GCTS 11-14-2024
- COYA 11-06-2024
- Dividend Yield
- GCTS N/A
- COYA N/A
- EPS Growth
- GCTS N/A
- COYA N/A
- EPS
- GCTS N/A
- COYA N/A
- Revenue
- GCTS $11,532,000.00
- COYA $9,554,315.00
- Revenue This Year
- GCTS N/A
- COYA N/A
- Revenue Next Year
- GCTS $459.37
- COYA $87.80
- P/E Ratio
- GCTS N/A
- COYA N/A
- Revenue Growth
- GCTS N/A
- COYA N/A
- 52 Week Low
- GCTS $2.12
- COYA $4.75
- 52 Week High
- GCTS $56.00
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- GCTS 42.13
- COYA 32.54
- Support Level
- GCTS $2.45
- COYA $5.07
- Resistance Level
- GCTS $2.70
- COYA $5.96
- Average True Range (ATR)
- GCTS 0.21
- COYA 0.38
- MACD
- GCTS -0.02
- COYA -0.06
- Stochastic Oscillator
- GCTS 15.85
- COYA 12.45
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.